VANGUARD GROUP INC 13D and 13G filings for Jazz Pharmaceuticals plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-27 10:20 am Sale | 2026-03-13 | 13G | JAZZ PHARMACEUTICALS PLC JAZZ | VANGUARD GROUP INC | 0 0.000% | -6,363,748 (Position Closed) | Filing |
| 2024-02-13 5:07 pm Sale | 2023-12-29 | 13G | JAZZ PHARMACEUTICALS PLC JAZZ | VANGUARD GROUP INC | 6,363,748 10.110% | -115,726 (-1.79%) | Filing |
| 2023-09-11 1:33 pm Purchase | 2023-08-31 | 13G | JAZZ PHARMACEUTICALS PLC JAZZ | VANGUARD GROUP INC | 6,479,474 10.260% | 428,849 (+7.09%) | Filing |
| 2023-02-09 11:25 am Purchase | 2022-12-30 | 13G | JAZZ PHARMACEUTICALS PLC JAZZ | VANGUARD GROUP INC | 6,050,625 9.610% | 505,924 (+9.12%) | Filing |
| 2022-02-10 08:22 am Purchase | 2021-12-31 | 13G | JAZZ PHARMACEUTICALS PLC JAZZ | VANGUARD GROUP INC | 5,544,701 9.020% | 666,808 (+13.67%) | Filing |